(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6.09%22.95B | 6.68%75.52B | 6.16%58.18B | 7.39%39.97B | 5.31%21.63B | 2.57%70.79B | 2.37%54.81B | 3.02%37.22B | 2.46%20.54B | 11.90%69.01B |
Operating income | 6.09%22.95B | 6.68%75.52B | 6.16%58.18B | 7.39%39.97B | 5.31%21.63B | 2.57%70.79B | 2.37%54.81B | 3.02%37.22B | 2.46%20.54B | 11.90%69.01B |
Operating expenses | -7.68%-17.87B | -6.64%-61.33B | -5.79%-46.51B | -7.22%-31.65B | -5.68%-16.59B | -3.10%-57.51B | -2.96%-43.97B | -3.21%-29.52B | -1.03%-15.7B | -8.88%-55.78B |
Gross profit | 0.87%5.08B | 6.85%14.19B | 7.68%11.67B | 8.04%8.32B | 4.09%5.04B | 0.33%13.28B | 0.03%10.84B | 2.31%7.71B | 7.39%4.84B | 26.75%13.23B |
Selling expenses | -1.21%-1.89B | -3.90%-6.1B | -5.51%-4.71B | -2.42%-3.26B | 0.40%-1.87B | 1.33%-5.88B | 2.42%-4.46B | -6.19%-3.19B | -4.30%-1.87B | -30.13%-5.95B |
Administrative expenses | -2.34%-644.08M | -9.16%-2.42B | -11.89%-1.77B | -12.31%-1.2B | -20.06%-629.33M | -9.15%-2.22B | -7.86%-1.58B | -10.10%-1.07B | -1.57%-524.18M | -10.19%-2.03B |
Research and development expenses | -3.76%-186.14M | 4.55%-782.14M | 12.78%-579.48M | 9.23%-400.57M | 24.90%-179.39M | 6.32%-819.45M | -9.87%-664.39M | -14.36%-441.32M | -28.35%-238.88M | -42.94%-874.72M |
Profit from asset sales | -93.60%23.28K | 1,643.51%12.03M | 73.40%1.53M | -20.73%439.94K | 4,114.74%363.93K | -0.68%689.82K | -52.53%881.98K | 347.60%554.97K | -84.10%8.63K | -76.49%694.51K |
Revaluation surplus | -41.05%8.24M | 1,175.97%38.64M | 491.21%21.33M | 4,726.36%44.05M | -41.95%13.98M | -101.82%-3.59M | 43.61%-5.45M | 84.69%-952.23K | 3,582.49%24.08M | 2,424.66%196.88M |
-Changes in the fair value of other assets | -41.05%8.24M | 1,175.97%38.64M | 491.21%21.33M | 4,726.36%44.05M | -41.95%13.98M | -101.82%-3.59M | 43.61%-5.45M | 84.69%-952.23K | 3,582.49%24.08M | 2,424.66%196.88M |
Impairment and provision | -0.64%-76.26M | -63.12%-86.67M | -129.60%-134.95M | -340.90%-96.47M | -151.25%-75.77M | 56.33%-53.13M | -5.28%-58.77M | 56.35%-21.88M | -33.15%-30.16M | 12.78%-121.67M |
-Other impairment is provision | -0.64%-76.26M | -63.12%-86.67M | -129.60%-134.95M | -340.90%-96.47M | -151.25%-75.77M | 56.33%-53.13M | -5.28%-58.77M | 56.35%-21.88M | -33.15%-30.16M | 12.78%-121.67M |
Special items of operating profit | 103.23%240.71M | -33.16%602.63M | 0.41%462.45M | -31.19%257.75M | 178.83%118.44M | 79.08%901.6M | 79.48%460.54M | 73.63%374.6M | -52.97%42.48M | -25.10%503.47M |
Operating profit | 4.96%2.43B | 3.86%5.1B | 9.63%4.71B | 9.09%3.49B | 8.52%2.32B | 5.56%4.91B | 3.72%4.3B | 0.97%3.2B | 8.26%2.14B | 26.52%4.65B |
Financing cost | -43.52%19.91M | -87.96%19.56M | -73.09%43.84M | -69.34%39.68M | -72.31%35.25M | 22.14%162.46M | 38.05%162.94M | 76.02%129.43M | 96.06%127.3M | 2,681.75%133.01M |
Special items of earning before tax | -95.91%91.02K | 66.62%-10.4M | 11.74%-3.83M | -349.72%-597.68K | 129.92%2.23M | 50.52%-31.16M | 92.44%-4.34M | 100.43%239.34K | -76.96%968.82K | -194.46%-62.97M |
Earning before tax | 4.13%2.45B | 1.33%5.11B | 6.63%4.75B | 6.02%3.53B | 4.03%2.35B | 6.78%5.04B | 5.99%4.46B | 4.48%3.33B | 10.87%2.26B | 26.32%4.72B |
Tax | -8.99%-420.62M | -7.76%-851.17M | -6.67%-823.71M | -4.74%-610.95M | -3.68%-385.93M | -4.75%-789.87M | -10.97%-772.22M | -8.06%-583.3M | -10.22%-372.24M | -16.47%-754.09M |
After-tax profit from continuing operations | 3.18%2.03B | 0.14%4.26B | 6.62%3.93B | 6.29%2.92B | 4.10%1.97B | 7.17%4.25B | 5.00%3.68B | 3.75%2.75B | 11.00%1.89B | 28.38%3.97B |
Earning after tax | 3.18%2.03B | 0.14%4.26B | 6.62%3.93B | 6.29%2.92B | 4.10%1.97B | 7.17%4.25B | 5.00%3.68B | 3.75%2.75B | 11.00%1.89B | 28.38%3.97B |
Minority profit | 21.76%73.61M | -29.00%203.65M | -34.65%137.48M | -30.48%110.49M | -29.63%60.45M | 15.15%286.85M | 6.55%210.37M | 8.03%158.94M | 12.11%85.91M | 41.23%249.11M |
Profit attributable to shareholders | 2.59%1.96B | 2.25%4.06B | 9.12%3.79B | 8.54%2.81B | 5.70%1.91B | 6.63%3.97B | 4.91%3.47B | 3.50%2.59B | 10.95%1.81B | 27.60%3.72B |
Basic earnings per share | 2.56%1.204 | 2.25%2.495 | 9.12%2.332 | 8.54%1.729 | 5.67%1.174 | 6.64%2.44 | 4.91%2.137 | 3.51%1.593 | 10.99%1.111 | 27.61%2.288 |
Diluted earnings per share | 2.56%1.204 | 2.25%2.495 | 9.12%2.332 | 8.54%1.729 | 5.67%1.174 | 6.64%2.44 | 4.91%2.137 | 3.51%1.593 | 10.99%1.111 | 27.61%2.288 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (special general partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data